IDENTIFICATION OF A NOVEL KEY REGULATOR OF ANTI-RENAL CANCER IMMUNOTHERAPY

$127,125FY2020Department of the ArmyDOD

Icahn School Of Medicine At Mount Sinai, New York NY

Investigators